Literature DB >> 34055182

The Psoriasis Decision Tree.

George Monks1,2, Ryan Rivera-Oyola1,2, Mark Lebwohl1,2.   

Abstract

Psoriasis, an inflammatory disorder of the skin, is associated with an increased risk of systemic diseases, such as psoriatic arthritis, psychiatric disorders, malignancy, and cardiometabolic and inflammatory bowel diseases. Careful consideration of the presence of these comorbidities should guide selection of appropriate therapy. The evolution of therapeutic targets for the treatment of psoriasis has significantly advanced available treatment options, potentially leading to uncertainty when selecting the optimal treatment for each patient. In this article, we review evidence-based guidelines for the use of psoriasis treatments in patients with distinct comorbidities, and group appropriate therapeutic options into a visual aid. An easy-to-use visual tool incorporating treatment options best suited for specific comorbidities can increase physicians' confidence when selecting the most appropriate treatment on an individualized basis.
Copyright © 2021. Matrix Medical Communications. All rights reserved.

Entities:  

Keywords:  Psoriasis; acitretin; biologics; brodalumab; comorbidities; cyclosporine; depression; guselkumab; inflammatory bowel disease; ixekizumab; kidney disease; liver disease; methotrexate; multiple sclerosis; pregnancy; psoriatic arthritis; risankizumab; secukinumab; tildrakizumab; ustekinumab

Year:  2021        PMID: 34055182      PMCID: PMC8142826     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  119 in total

1.  Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.

Authors:  Zobair M Younossi; Maria Stepanova; Mariam Afendy; Yun Fang; Youssef Younossi; Hesham Mir; Manirath Srishord
Journal:  Clin Gastroenterol Hepatol       Date:  2011-03-25       Impact factor: 11.382

2.  Analysis of 629 pregnancy outcomes in transplant recipients treated with Sandimmun.

Authors:  V Lamarque; M F Leleu; C Monka; P Krupp
Journal:  Transplant Proc       Date:  1997-08       Impact factor: 1.066

3.  Prospective analysis of psoriatic arthritis in patients hospitalized for psoriasis.

Authors:  D G Leonard; J D O'Duffy; R S Rogers
Journal:  Mayo Clin Proc       Date:  1978-08       Impact factor: 7.616

4.  Methotrexate and Vasculoprotection: Mechanistic Insights and Potential Therapeutic Applications in Old Age.

Authors:  Arduino A Mangoni; Sara Tommasi; Angelo Zinellu; Salvatore Sotgia; Stefania Bassu; Matteo Piga; Gian L Erre; Ciriaco Carru
Journal:  Curr Pharm Des       Date:  2019       Impact factor: 3.116

5.  The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study.

Authors:  Shanu Kohli Kurd; Andrea B Troxel; Paul Crits-Christoph; Joel M Gelfand
Journal:  Arch Dermatol       Date:  2010-08

6.  Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K.

Authors:  K Abuabara; R S Azfar; D B Shin; A L Neimann; A B Troxel; J M Gelfand
Journal:  Br J Dermatol       Date:  2010-09       Impact factor: 9.302

7.  Exposition to anti-TNF drugs during pregnancy: outcome of 15 cases and review of the literature.

Authors:  Jean-Marie Berthelot; Michel De Bandt; Philippe Goupille; Elisabeth Solau-Gervais; Frédéric Lioté; Vincent Goeb; Isabelle Azaïs; Antoine Martin; Béatrice Pallot-Prades; Yves Maugars; Xavier Mariette
Journal:  Joint Bone Spine       Date:  2008-12-06       Impact factor: 4.929

Review 8.  Psoriasis: Which therapy for which patient: Psoriasis comorbidities and preferred systemic agents.

Authors:  Shivani B Kaushik; Mark G Lebwohl
Journal:  J Am Acad Dermatol       Date:  2018-07-11       Impact factor: 11.527

9.  The Incidence and Risk Factors for Psoriatic Arthritis in Patients With Psoriasis: A Prospective Cohort Study.

Authors:  Lihi Eder; Amir Haddad; Cheryl F Rosen; Ker-Ai Lee; Vinod Chandran; Richard Cook; Dafna D Gladman
Journal:  Arthritis Rheumatol       Date:  2016-04       Impact factor: 10.995

10.  US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey.

Authors:  Mark G Lebwohl; Arthur Kavanaugh; April W Armstrong; Abby S Van Voorhees
Journal:  Am J Clin Dermatol       Date:  2016-02       Impact factor: 7.403

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.